Nan Xu

3.0k total citations
114 papers, 2.1k citations indexed

About

Nan Xu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Nan Xu has authored 114 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 33 papers in Molecular Biology and 24 papers in Epidemiology. Recurrent topics in Nan Xu's work include CAR-T cell therapy research (28 papers), Liver Disease Diagnosis and Treatment (15 papers) and Advancements in Semiconductor Devices and Circuit Design (6 papers). Nan Xu is often cited by papers focused on CAR-T cell therapy research (28 papers), Liver Disease Diagnosis and Treatment (15 papers) and Advancements in Semiconductor Devices and Circuit Design (6 papers). Nan Xu collaborates with scholars based in China, United States and Macao. Nan Xu's co-authors include Imran Rizvi, Bryan Q. Spring, Tayyaba Hasan, Lei Yu, Ziren Su, Jianghan Chen, Liqing Kang, Xue Wu, Yuxuan Gan and Huijuan Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and ACS Nano.

In The Last Decade

Nan Xu

106 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Xu China 24 803 486 405 358 272 114 2.1k
Yong Luo China 27 690 0.9× 294 0.6× 435 1.1× 218 0.6× 191 0.7× 99 2.1k
Jaehong Kim South Korea 20 946 1.2× 373 0.8× 374 0.9× 127 0.4× 252 0.9× 54 2.2k
Wen‐Wei Chang Taiwan 31 1.3k 1.7× 538 1.1× 309 0.8× 315 0.9× 194 0.7× 77 2.6k
Patrício Godoy Germany 29 851 1.1× 294 0.6× 577 1.4× 288 0.8× 81 0.3× 72 2.4k
Asmita Das India 19 701 0.9× 575 1.2× 169 0.4× 297 0.8× 163 0.6× 58 2.0k
Rui Yang China 31 1.3k 1.6× 349 0.7× 334 0.8× 177 0.5× 152 0.6× 115 2.8k
Jun Ye China 23 662 0.8× 239 0.5× 154 0.4× 202 0.6× 134 0.5× 67 1.7k
Hao Peng China 30 1.2k 1.4× 273 0.6× 155 0.4× 234 0.7× 180 0.7× 126 2.7k
Yingjie Xu China 26 1.7k 2.2× 312 0.6× 181 0.4× 231 0.6× 165 0.6× 92 2.8k

Countries citing papers authored by Nan Xu

Since Specialization
Citations

This map shows the geographic impact of Nan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Xu more than expected).

Fields of papers citing papers by Nan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Xu. The network helps show where Nan Xu may publish in the future.

Co-authorship network of co-authors of Nan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Xu. A scholar is included among the top collaborators of Nan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Xu. Nan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Nan, et al.. (2024). BERT-siRNA: siRNA target prediction based on BERT pre-trained interpretable model. Gene. 910. 148330–148330. 3 indexed citations
2.
Zhang, Shuyue, Nan Xu, Kun Liu, et al.. (2024). Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration. International Journal of Nanomedicine. Volume 19. 1887–1908. 11 indexed citations
3.
4.
5.
6.
Wei, Zhenyu, et al.. (2024). PrCRS: a prediction model of severe CRS in CAR-T therapy based on transfer learning. BMC Bioinformatics. 25(1). 197–197. 4 indexed citations
7.
Chen, Shun, et al.. (2024). A molecularly engineered fully bio-derived phosphorylated furan-based flame retardant for biomass-based fabrics. International Journal of Biological Macromolecules. 263(Pt 2). 129836–129836. 15 indexed citations
8.
Chen, Liyun, Wenjie Gong, Haixia Zhou, et al.. (2023). Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia. Blood Advances. 7(17). 4913–4925. 8 indexed citations
9.
Li, Minyao, Muxia Li, Nan Xu, et al.. (2023). Huangqin Decoction ameliorates ulcerative colitis by regulating fatty acid metabolism to mediate macrophage polarization via activating FFAR4-AMPK-PPARα pathway. Journal of Ethnopharmacology. 311. 116430–116430. 25 indexed citations
10.
Xu, Nan, Jingwen Tan, Weixin Xie, et al.. (2022). ILGBMSH: an interpretable classification model for the shRNA target prediction with ensemble learning algorithm. Briefings in Bioinformatics. 23(6). 12 indexed citations
11.
Liu, Rui, Qian Cheng, Liqing Kang, et al.. (2022). CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma. Human Gene Therapy. 33(5-6). 318–329. 17 indexed citations
12.
Wei, Zhenyu, Nan Xu, Liqing Kang, et al.. (2022). Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk. BMC Bioinformatics. 23(1). 373–373. 10 indexed citations
13.
Phillips, Darren C., Fritz G. Buchanan, Dong Cheng, et al.. (2021). Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors. Cancer Research. 81(12). 3402–3414. 32 indexed citations
14.
Liu, Jingjing, Nan Xu, Xinyu Wang, et al.. (2021). Quantitative radio-thin-layer chromatography and positron emission tomography studies for measuring streptavidin transduced chimeric antigen receptor T cells. Journal of Chromatography B. 1182. 122944–122944. 4 indexed citations
15.
Zhang, Ying, Jiaqi Li, Xiaoyan Lou, et al.. (2021). A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Frontiers in Oncology. 11. 664421–664421. 35 indexed citations
16.
Lin, Guosheng, Minyao Li, Nan Xu, et al.. (2020). Anti‐Inflammatory Effects of Heritiera littoralis Fruits on Dextran Sulfate Sodium‐ (DSS‐) Induced Ulcerative Colitis in Mice by Regulating Gut Microbiota and Suppressing NF‐κB Pathway. BioMed Research International. 2020(1). 8893621–8893621. 10 indexed citations
17.
18.
Kang, Liqing, Xiaowen Tang, Nan Xu, et al.. (2019). shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia. Blood. 134(Supplement_1). 2621–2621. 2 indexed citations
19.
Hong, Nan, Nan Xu, Abdullah M. S. Al‐Hatmi, et al.. (2018). Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China. Mycoses. 62(2). 171–180. 11 indexed citations
20.
Xu, Nan. (2012). Isolation and identification of phenols constituents from whole plant of Leontopodium leontopodioides. Shenyang Yaoke Daxue xuebao. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Luo Breakdown of academic impact, for papers by Jaehong Kim Breakdown of academic impact, for papers by Wen‐Wei Chang Breakdown of academic impact, for papers by Patrício Godoy Breakdown of academic impact, for papers by Asmita Das Breakdown of academic impact, for papers by Rui Yang Breakdown of academic impact, for papers by Jun Ye Breakdown of academic impact, for papers by Hao Peng Breakdown of academic impact, for papers by Yingjie Xu
Rankless by CCL
2026